3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
7
Carcinoma, Non-Small-Cell Lung
7
Glioblastoma
6
Rectal Neoplasms
5
Breast Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Oropharyngeal Neoplasms
4
Lung Neoplasms
4
Burkitt Lymphoma
4
Urinary Bladder Neoplasms
3
Mouth Neoplasms
3
Glioma
3
Astrocytoma
3
Adenocarcinoma of Lung
3
Rhabdomyosarcoma
2
Pancreatic Neoplasms
2
Mesothelioma, Malignant
2
Lymphoma, Follicular
2
Laryngeal Neoplasms
2
Hodgkin Disease
2
Esophageal Neoplasms
2
Carcinoma, Squamous Cell
2
Carcinoma
2
Breast Carcinoma In Situ
2
Adenocarcinoma, Bronchiolo-Alveolar
2
Wilms Tumor
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Sinonasal Squamous Cell Carcinoma
1
Interventions
Magnetic Resonance Spectroscopy
4
Specimen Handling
3
Nivolumab
3
ulixertinib
2
binimetinib
2
Ipilimumab
2
CTLA-4 Antigen
2
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
trametinib
1
tipifarnib
1
selpercatinib
1
sapanisertib
1
repotrectinib
1
relatlimab
1
pertuzumab
1
palbociclib
1
osimertinib
1
omipalisib
1
larotrectinib
1
ipatasertib
1
erdafitinib
1
defactinib
1
dabrafenib
1
copanlisib
1
capivasertib
1
cabozantinib
1
adavosertib
1
X-Rays
1
Trastuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Thyroid Neoplasms
×
Radiotherapy
×
30 days
×
Clear all
No trials found.